Michael A. Uberall

Nuernberg, BY 90411, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

Age-Dependent Safety and Effectiveness of Pridinol Versus NSAIDs in Acute (Low) Back Pain: A Secondary Analysis of the Providence Real-World Study.

Age-Dependent Safety and Effectiveness of Pridinol Versus NSAIDs in Acute (Low) Back Pain: A Secondary Analysis of the Providence Real-World Study.

Journal: Journal of clinical medicine
Published: April 01, 2026

Beyond Methodological Considerations: Clinical Implications of Real-World Evidence from the CARE Study [Response to Letter].

Beyond Methodological Considerations: Clinical Implications of Real-World Evidence from the CARE Study [Response to Letter].

Journal: Journal of pain research
Published: March 24, 2026

German Expert Consensus on Opioid-Induced Constipation (OIC): Recommendations and a Treatment Algorithm for Clinical Practice.

German Expert Consensus on Opioid-Induced Constipation (OIC): Recommendations and a Treatment Algorithm for Clinical Practice.

Journal: Journal of clinical medicine
Published: January 16, 2026

PRIME-Teen-Treatment Persistence and Outcomes Associated with CGRP Monoclonal Antibodies Compared with Conventional Oral Preventives in Adolescents with High-Burden Migraine: An Exploratory Real-World Analysis from the German Pain e-Registry (GPeR).

PRIME-Teen-Treatment Persistence and Outcomes Associated with CGRP Monoclonal Antibodies Compared with Conventional Oral Preventives in Adolescents with High-Burden Migraine: An Exploratory Real-World Analysis from the German Pain e-Registry (GPeR).

Journal: Journal of clinical medicine
Published: December 31, 2025

Treatment Persistence in Migraine Prophylaxis Comparing CGRP Monoclonal Antibodies vs. High-/Low-Evidence Conventional Oral Preventives-A Comparative Real-World Evidence Study of Depersonalized Data of the German Pain e-Registry.

Treatment Persistence in Migraine Prophylaxis Comparing CGRP Monoclonal Antibodies vs. High-/Low-Evidence Conventional Oral Preventives-A Comparative Real-World Evidence Study of Depersonalized Data of the German Pain e-Registry.

Journal: Journal of clinical medicine
Published: December 30, 2025

Efficacy and Tolerability of Pridinol Mesylate Versus Quinine Sulfate in the Treatment of Nocturnal Leg Cramps: A Propensity Score-Matched Real-World Analysis of Depersonalized 4-Week Data from the German Pain e-Registry (PRISCILA Study).

Efficacy and Tolerability of Pridinol Mesylate Versus Quinine Sulfate in the Treatment of Nocturnal Leg Cramps: A Propensity Score-Matched Real-World Analysis of Depersonalized 4-Week Data from the German Pain e-Registry (PRISCILA Study).

Journal: Journal of clinical medicine
Published: December 30, 2025

Self-Efficacy as a Central Mediator of Pain, Function, and Depression: Insights of a Cross-Sectional Analysis of Depersonalized Data from the German Pain e-Registry.

Self-Efficacy as a Central Mediator of Pain, Function, and Depression: Insights of a Cross-Sectional Analysis of Depersonalized Data from the German Pain e-Registry.

Journal: Journal of clinical medicine
Published: December 30, 2025

Progressive Improvements with Repeated High-Concentration Capsaicin Patch: Real-World Data from the Retrospective CASPAR German Pain e-Registry Study in Postherpetic Neuralgia.

Progressive Improvements with Repeated High-Concentration Capsaicin Patch: Real-World Data from the Retrospective CASPAR German Pain e-Registry Study in Postherpetic Neuralgia.

Journal: Dermatology and therapy
Published: October 29, 2025

Real-world 12-month outcomes of repeated high-concentration capsaicin patch in chemotherapy-induced peripheral neuropathy: results from the CASPAR study.

Real-world 12-month outcomes of repeated high-concentration capsaicin patch in chemotherapy-induced peripheral neuropathy: results from the CASPAR study.

Journal: Frontiers in oncology
Published: September 23, 2025

CARE - A Retrospective, Dual-Cohort, 24-Week Real-World Study from the German Pain e-Registry on the Effectiveness and Safety of CBD-Dominant Oral Cannabis Extracts versus THC/Dronabinol in Older Patients with Chronic Pain.

CARE - A Retrospective, Dual-Cohort, 24-Week Real-World Study from the German Pain e-Registry on the Effectiveness and Safety of CBD-Dominant Oral Cannabis Extracts versus THC/Dronabinol in Older Patients with Chronic Pain.

Journal: Journal of pain research
Published: July 04, 2025

Safety, Tolerability, and Efficacy of Hox Alpha, a Dry Extract from Stinging Nettle Leaves versus OTC NSAIDs in Osteoarthritis: A Retrospective, Propensity-Matched 12-Week Analysis from the German Pain e-Registry (SIPHARO Study).

Safety, Tolerability, and Efficacy of Hox Alpha, a Dry Extract from Stinging Nettle Leaves versus OTC NSAIDs in Osteoarthritis: A Retrospective, Propensity-Matched 12-Week Analysis from the German Pain e-Registry (SIPHARO Study).

Journal: Journal of pain research
Published: June 12, 2025

Progressive Response of Repeated Treatment with High-Concentration (179 mg) Capsaicin Patch in Peripheral Neuropathic Pain After Surgical or Traumatic Nerve Injury: Findings from the 12-Month German CASPAR Registry Study.

Progressive Response of Repeated Treatment with High-Concentration (179 mg) Capsaicin Patch in Peripheral Neuropathic Pain After Surgical or Traumatic Nerve Injury: Findings from the 12-Month German CASPAR Registry Study.

Journal: Pain and therapy
Published: March 27, 2025
Showing 1-12 of 44

Last Updated: 09/26/2026